Navigation Links
US Patent awarded for using Metal Peptides to Help Diminish Skin Imperfections
Date:7/11/2012

BELLEVUE, Wash., July 11, 2012 /PRNewswire/ -- Summit Associates International today announced that it was awarded US Patent 8,183,204, on methods and compositions for increasing skin remodeling. The patent describes the use of metal peptides for helping to diminish or remove various skin imperfections, including wound and surgical scars, acne scars, keloids, skin tags, benign skin moles, stretch marks, facial keratosis, sunspots, or a vitiligo.

The inventor, Dr. Loren Pickart, previously discovered the human skin-remodeling, copper-binding peptide GHK, and then developed clinically-proven methods for its use in cosmetic skin improvement, hair growth, and hair transplantation. Recent published work from numerous universities found that GHK controls or heavily influences 17% of the human genome, and also possesses a multiplicity of "wellness" properties including regeneration of tissues, activation of quiescent stem cells, suppression of numerous cancer metastasis genes, plus anti-inflammatory and anti-infection actions.

"The real cause of aging and most diseases is the silencing of regenerative and protective genes," said Dr. Pickart, "At age 25, our genes produce the healthiest mix of proteins, then gene silencing reduces the effect of our regenerative genes and increases the influence inflammatory and cancer-promoting genes. Summit Associates is also focused on developing and patenting methods of re-programming the human gene pattern to inhibit cancer growth and the effects of human senescence."

Summit Associates is Dr. Pickart's research group and located in Bellevue, WA. More information can be found at www.summit-associates-intl.com


Media contact:
Dr. Loren Pickart
425-644-0160
Email lorenpickart@summit-associate-intl.com


'/>"/>
SOURCE Summit Associates International
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Enbrel® (etanercept) Patent Issued
2. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
3. Cenestra Health Announces Granting of Broad Patent Covering Proprietary Bioactive Lipid Formulations
4. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
5. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
6. Bio-AMD, Inc.; DSR Commercial Refinement, Prospective Patent Applications
7. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
8. Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain
9. NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents
10. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
11. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):